Our new study,Cancer Prevention Project 3, will focus first on finding the right dose of aspirin for people with a mismatch repair gene defect, the underlying cause of Lynch syndrome We already have regular contact with many people in CAPP2 but we would very much like to hear from everyone who took part, even if they dropped out early